You are currently viewing a new version of our website. To view the old version click .

70 Results Found

  • Article
  • Open Access
8 Citations
4,402 Views
11 Pages

12 September 2019

Amyloid beta-peptide is produced by the cleavage of amyloid precursor protein by two secretases, a β-secretase, beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and a γ-secretase. It has been hypothesised that partial inhibiti...

  • Article
  • Open Access
33 Citations
3,940 Views
13 Pages

22 September 2019

Epidermal growth factor receptor (EGFR) is associated with the progression of a wide range of cancers including breast, glioma, lung, and liver cancer. The observation that EGFR inhibition can limit the growth of EGFR positive cancers has led to the...

  • Review
  • Open Access
1 Citations
2,124 Views
14 Pages

Conditional Control of CRISPR/Cas9 Function by Chemically Modified Oligonucleotides

  • Liangliang Wang,
  • Yan Liu,
  • Hongjun Song,
  • Xue Zhang and
  • Yang Wang

28 April 2025

The CRISPR (clustered regularly interspaced short palindromic repeats) system has emerged as a revolutionary gene-editing tool with immense potential in gene therapy, functional genomics, and beyond. However, achieving precise spatiotemporal control...

  • Review
  • Open Access
97 Citations
11,499 Views
29 Pages

14 September 2015

The enzymatic co-polymerization of modified nucleoside triphosphates (dN*TPs and N*TPs) is a versatile method for the expansion and exploration of expanded chemical space in SELEX and related combinatorial methods of in vitro selection. This strategy...

  • Article
  • Open Access
1 Citations
2,701 Views
13 Pages

Synthesis and Behavior of DNA Oligomers Containing the Ambiguous Z-Nucleobase 5-Aminoimidazole-4-carboxamide

  • Yuhei Nogi,
  • Noriko Saito-Tarashima,
  • Sangita Karanjit and
  • Noriaki Minakawa

5-Amino-1-β-D-ribofuranosylimidazole-4-carboxamide 5′-monophosphate (ZMP) is a central intermediate in de novo purine nucleotide biosynthesis. Its nucleobase moiety, 5-aminoimidazole-4-carboxamide (Z-base), is considered an ambiguous base...

  • Article
  • Open Access
6 Citations
8,491 Views
11 Pages

DNA Three Way Junction Core Decorated with Amino Acids-Like Residues-Synthesis and Characterization

  • Claudia Addamiano,
  • Béatrice Gerland,
  • Corinne Payrastre and
  • Jean-Marc Escudier

23 August 2016

Construction and physico-chemical behavior of DNA three way junction (3WJ) functionalized by protein-like residues (imidazole, alcohol and carboxylic acid) at unpaired positions at the core is described. One 5′-C(S)-propargyl-thymidine nucleotide was...

  • Communication
  • Open Access
1 Citations
2,935 Views
19 Pages

Systematic Analysis of 2′-O-Alkyl Modified Analogs for Enzymatic Synthesis and Their Oligonucleotide Properties

  • Kenta Ishida,
  • Yuuya Kasahara,
  • Hidekazu Hoshino,
  • Takumi Okuda and
  • Satoshi Obika

2 December 2023

Enzymatic oligonucleotide synthesis is used for the development of functional oligonucleotides selected by in vitro selection. Expanding available sugar modifications for in vitro selection helps the functional oligonucleotides to be used as therapeu...

  • Feature Paper
  • Article
  • Open Access
2 Citations
4,200 Views
14 Pages

3 December 2022

Oligonucleotides with an amino linker at the 3′-end are useful for the preparation of conjugated oligonucleotides. However, chemically modified nucleosides, which are unstable under basic conditions, cannot be incorporated into oligonucleotides...

  • Article
  • Open Access
3,201 Views
16 Pages

Improved Metal-Free Approach for the Synthesis of Protected Thiol Containing Thymidine Nucleoside Phosphoramidite and Its Application for the Synthesis of Ligatable Oligonucleotide Conjugates

  • Zoltán Kupihár,
  • Györgyi Ferenc,
  • Vencel L. Petrovicz,
  • Viktória R. Fáy,
  • Lajos Kovács,
  • Tamás A. Martinek and
  • Zsófia Hegedüs

Oligonucleotide conjugates are versatile scaffolds that can be applied in DNA-based screening platforms and ligand display or as therapeutics. Several different chemical approaches are available for functionalizing oligonucleotides, which are often c...

  • Review
  • Open Access
84 Citations
9,615 Views
23 Pages

13 October 2020

In the last three decades, oligonucleotides have been extensively investigated as probes, molecular ligands and even catalysts within therapeutic and diagnostic applications. The narrow chemical repertoire of natural nucleic acids, however, imposes r...

  • Review
  • Open Access
46 Citations
9,100 Views
20 Pages

Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

  • Yating Sun,
  • Yarong Zhao,
  • Xiuting Zhao,
  • Robert J. Lee,
  • Lesheng Teng and
  • Chenguang Zhou

13 October 2017

Oligonucleotide (ON) drugs, including small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotides, are promising therapeutic agents. However, their low membrane permeability and sensitivity to nucleases present challenges to in viv...

  • Article
  • Open Access
13 Citations
5,642 Views
13 Pages

Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents

  • Madhuri Hande,
  • Osama Saher,
  • Karin E. Lundin,
  • C. I. Edvard Smith,
  • Rula Zain and
  • Tuomas Lönnberg

26 March 2019

2’-O-Methylribo phosphorothioate oligonucleotides incorporating cyclopalladated benzylamine conjugate groups at their 5’-termini have been prepared and their ability to hybridize with a designated target sequence was assessed by conventio...

  • Article
  • Open Access
5 Citations
3,437 Views
11 Pages

17 September 2018

A novel 2′-F,4′-C-OMe–arabinouridine (araU) was successfully synthesized and introduced into oligonucleotides. The oligonucleotide containing 2′-F,4′-C-OMe–araU exhibited improved nuclease resistance and RNA hybrid...

  • Review
  • Open Access
74 Citations
10,951 Views
13 Pages

2023 FDA TIDES (Peptides and Oligonucleotides) Harvest

  • Danah Al Shaer,
  • Othman Al Musaimi,
  • Fernando Albericio and
  • Beatriz G. de la Torre

13 February 2024

A total of nine TIDES (pepTIDES and oligonucleoTIDES) were approved by the FDA during 2023. The four approved oligonucleotides are indicated for various types of disorders, including amyotrophic lateral sclerosis, geographic atrophy, primary hyperoxa...

  • Review
  • Open Access
35 Citations
9,919 Views
37 Pages

Synthesis of Nucleobase-Modified RNA Oligonucleotides by Post-Synthetic Approach

  • Karolina Bartosik,
  • Katarzyna Debiec,
  • Anna Czarnecka,
  • Elzbieta Sochacka and
  • Grazyna Leszczynska

23 July 2020

The chemical synthesis of modified oligoribonucleotides represents a powerful approach to study the structure, stability, and biological activity of RNAs. Selected RNA modifications have been proven to enhance the drug-like properties of RNA oligomer...

  • Article
  • Open Access
48 Citations
10,806 Views
18 Pages

Piezoelectric Sensor for Determination of Genetically Modified Soybean Roundup Ready (R) in Samples not Amplified by PCR

  • Magdalena Stobiecka,
  • Jarosław M. Cieśla,
  • Beata Janowska,
  • Barbara Tudek and
  • Hanna Radecka

14 August 2007

The chemically modified piezoelectrodes were utilized to develop relativelycheap and easy to use biosensor for determination of genetically modified Roundup Readysoybean (RR soybean). The biosensor relies on the immobilization onto goldpiezoelectrode...

  • Article
  • Open Access
3 Citations
2,993 Views
14 Pages

Oligonucleotide therapeutics, antisense oligonucleotides (ASOs) and short interfering RNA (siRNA) are short synthetic nucleic acid molecules with a promising potential to treat a wide range of diseases. Despite considerable progress in the field, the...

  • Article
  • Open Access
19 Citations
10,138 Views
7 Pages

Assembly method fabricating linkers for covalently bonding DNA on glass surface

  • Jiong Li,
  • Hong Wang,
  • Yujie Zhao,
  • Lu Cheng,
  • Nongyue He and
  • Zuhong Lu

20 July 2001

A fabrication method of linkers to covalently anchor nucleic acid probes (such as, oligonucleotides, PCR-products or peptide nucleic acid oligomers) on glass was developed by alternatively covalently assembling the different molecular components. The...

  • Article
  • Open Access
5 Citations
3,200 Views
19 Pages

13 December 2023

Cancer is one of the leading causes of death globally. Epidermal growth factor receptor is one of the proteins involved in cancer cell proliferation, differentiation, and invasion. Antisense oligonucleotides are chemical nucleic acids that bind to ta...

  • Review
  • Open Access
25 Citations
6,800 Views
35 Pages

This review covers studies which exploit triazole-modified nucleic acids in the range of chemistry and biology to medicine. The 1,2,3-triazole unit, which is obtained via click chemistry approach, shows valuable and unique properties. For example, it...

  • Review
  • Open Access
14 Citations
4,790 Views
13 Pages

Modulating Immune Response with Nucleic Acid Nanoparticles

  • Jake K. Durbin,
  • Daniel K. Miller,
  • Julia Niekamp and
  • Emil F. Khisamutdinov

17 October 2019

Nano-objects made of nucleic acids are becoming promising materials in the biomedical field. This is, in part, due to DNA and RNA self-assembly properties that can be accurately computed to fabricate various complex nanoarchitectures of 2D and 3D sha...

  • Article
  • Open Access
2 Citations
3,826 Views
14 Pages

Structure and Oligonucleotide Binding Efficiency of Differently Prepared Click Chemistry-Type DNA Microarray Slides Based on 3-Azidopropyltrimethoxysilane

  • Emilia Frydrych-Tomczak,
  • Tomasz Ratajczak,
  • Łukasz Kościński,
  • Agnieszka Ranecka,
  • Natalia Michalak,
  • Tadeusz Luciński,
  • Hieronim Maciejewski,
  • Stefan Jurga,
  • Mikołaj Lewandowski and
  • Marcin K. Chmielewski

26 May 2021

The structural characterization of glass slides surface-modified with 3-azidopropyltrimethoxysilane and used for anchoring nucleic acids, resulting in the so-called DNA microarrays, is presented. Depending on the silanization conditions, the slides w...

  • Article
  • Open Access
3 Citations
2,994 Views
15 Pages

Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells

  • Manuel Fernández-Delgado,
  • Luis Sendra,
  • María José Herrero,
  • Gladys G. Olivera-Pasquini,
  • Alexander Batista-Duharte and
  • Salvador F. Aliño

Therapeutic oligonucleotides have achieved great clinical interest since their approval as drug agents by regulatory agencies but their access and distribution in blood cells are not completely known. We evaluated by flow cytometry the ability of sho...

  • Review
  • Open Access
1 Citations
1,846 Views
27 Pages

Recent advances in genetics and nucleic acid chemistry have created fundamentally new tools, both for practical applications in therapy and diagnostics and for fundamental genome editing tasks. Nucleic acid-based therapeutic agents offer a distinct a...

  • Communication
  • Open Access
25 Citations
11,228 Views
16 Pages

Modified Nucleotides as Substrates of Terminal Deoxynucleotidyl Transferase

  • Daiva Tauraitė,
  • Jevgenija Jakubovska,
  • Julija Dabužinskaitė,
  • Maksim Bratchikov and
  • Rolandas Meškys

The synthesis of novel modified nucleotides and their incorporation into DNA sequences opens many possibilities to change the chemical properties of oligonucleotides (ONs), and, therefore, broaden the field of practical applications of modified DNA....

  • Review
  • Open Access
55 Citations
11,675 Views
22 Pages

G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents

  • Domenica Musumeci,
  • Claudia Riccardi and
  • Daniela Montesarchio

22 September 2015

Though a variety of different non-canonical nucleic acids conformations have been recognized, G-quadruplex structures are probably the structural motifs most commonly found within known oligonucleotide-based aptamers. This could be ascribed to severa...

  • Review
  • Open Access
23 Citations
6,800 Views
17 Pages

Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis

  • Eriko Toyoda,
  • Miki Maehara,
  • Masahiko Watanabe and
  • Masato Sato

Osteoarthritis (OA) of the knee is a disease that significantly decreases the quality of life due to joint deformation and pain caused by degeneration of articular cartilage. Since the degeneration of cartilage is irreversible, intervention from an e...

  • Review
  • Open Access
29 Citations
15,795 Views
27 Pages

RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays

  • Zhichao Tang,
  • Junxing Zhao,
  • Zach J. Pearson,
  • Zarko V. Boskovic and
  • Jingxin Wang

14 April 2021

RNA splicing is an essential step in producing mature messenger RNA (mRNA) and other RNA species. Harnessing RNA splicing modifiers as a new pharmacological modality is promising for the treatment of diseases caused by aberrant splicing. This drug mo...

  • Article
  • Open Access
2 Citations
1,868 Views
20 Pages

27 January 2025

Gapmer-type antisense oligonucleotides (ASOs) are an emerging class of therapeutic agents that directly inhibit pathogenic mRNA. In this study, three new 4′-C-substituted thymidine analogs were generated using a synthetic strategy recently esta...

  • Review
  • Open Access
12 Citations
5,614 Views
19 Pages

24 December 2021

Nucleic-acid-based small molecule and oligonucleotide therapies are attractive topics due to their potential for effective target of disease-related modules and specific control of disease gene expression. As the non-naturally occurring biomolecules,...

  • Abstract
  • Open Access
1,047 Views
1 Page

Strategies for inhibiting gene expression have been applied in several therapeutic applications Indeed, administration of nucleic acids such as antisense oligonucleotides (AS-ODNs) or small interfering RNA (siRNA) has raised a lot of interests in the...

  • Article
  • Open Access
52 Citations
6,593 Views
15 Pages

Reduced Graphene Oxides: Influence of the Reduction Method on the Electrocatalytic Effect towards Nucleic Acid Oxidation

  • Daniela F. Báez,
  • Helena Pardo,
  • Ignacio Laborda,
  • José F. Marco,
  • Claudia Yáñez and
  • Soledad Bollo

For the first time a critical analysis of the influence that four different graphene oxide reduction methods have on the electrochemical properties of the resulting reduced graphene oxides (RGOs) is reported. Starting from the same graphene oxide, ch...

  • Feature Paper
  • Review
  • Open Access
195 Citations
14,310 Views
22 Pages

Aptamer Therapeutics in Cancer: Current and Future

  • Yoshihiro Morita,
  • Macall Leslie,
  • Hiroyasu Kameyama,
  • David E. Volk and
  • Takemi Tanaka

19 March 2018

Aptamer-related technologies represent a revolutionary advancement in the capacity to rapidly develop new classes of targeting ligands. Structurally distinct RNA and DNA oligonucleotides, aptamers mimic small, protein-binding molecules and exhibit hi...

  • Review
  • Open Access
12 Citations
12,637 Views
14 Pages

Visible Genotype Sensor Array

  • Yuichi Michikawa,
  • Tomo Suga,
  • Yoshimi Ohtsuka,
  • Izumi Matsumoto,
  • Atsuko Ishikawa,
  • Kenichi Ishikawa,
  • Mayumi Iwakawa and
  • Takashi Imai

17 April 2008

A visible sensor array system for simultaneous multiple SNP genotyping has been developed using a new plastic base with specific surface chemistry. Discrimination of SNP alleles is carried out by an allele-specific extension reaction using immobilize...

  • Feature Paper
  • Review
  • Open Access
155 Citations
15,433 Views
33 Pages

Current Advances in Aptamers for Cancer Diagnosis and Therapy

  • Shin-ichiro Hori,
  • Alberto Herrera,
  • John J. Rossi and
  • Jiehua Zhou

3 January 2018

Nucleic acid aptamers are single-stranded oligonucleotides that interact with target molecules with high affinity and specificity in unique three-dimensional structures. Aptamers are generally isolated by a simple selection process called systematic...

  • Brief Report
  • Open Access
65 Citations
11,050 Views
6 Pages

Tegsedi (Inotersen) is a chemically modified antisense oligonucleotide that inhibits the hepatic production of transthyretin (TTR). Several single-point mutations in TTR destabilize its structure, leading to the aggregation and accumulation of amyloi...

  • Review
  • Open Access
36 Citations
8,753 Views
58 Pages

DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors

  • Anastasiya N. Shishparenok,
  • Vitalina V. Furman and
  • Dmitry D. Zhdanov

5 April 2023

DNA nanotechnology has significantly advanced and might be used in biomedical applications, drug delivery, and cancer treatment during the past few decades. DNA nanomaterials are widely used in biomedical research involving biosensing, bioimaging, an...

  • Review
  • Open Access
55 Citations
13,139 Views
37 Pages

Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology

  • Man Amanat,
  • Christina L. Nemeth,
  • Amena Smith Fine,
  • Doris G. Leung and
  • Ali Fatemi

Antisense oligonucleotides (ASOs) are disease-modifying agents affecting protein-coding and noncoding ribonucleic acids. Depending on the chemical modification and the location of hybridization, ASOs are able to reduce the level of toxic proteins, in...

  • Review
  • Open Access
3 Citations
3,631 Views
21 Pages

The Role of microRNA-22 in Metabolism

  • Simone Tomasini,
  • Paolo Vigo,
  • Francesco Margiotta,
  • Ulrik Søberg Scheele,
  • Riccardo Panella and
  • Sakari Kauppinen

microRNA-22 (miR-22) plays a pivotal role in the regulation of metabolic processes and has emerged as a therapeutic target in metabolic disorders, including obesity, type 2 diabetes, and metabolic-associated liver diseases. While miR-22 exhibits cont...

  • Article
  • Open Access
10 Citations
4,516 Views
23 Pages

29 October 2020

Antisense DNA oligonucleotides, short interfering RNAs (siRNAs), and CRISPR/Cas9 genetic tools are the most useful therapeutic nucleic acids regulating gene expression based on the antisense specificity towards messenger RNA. Here, we present an effe...

  • Review
  • Open Access
3 Citations
4,098 Views
22 Pages

Novel RNA-Based Therapies in the Management of Dyslipidemias

  • Constantine E. Kosmas,
  • Maria D. Bousvarou,
  • Donatos Tsamoulis,
  • Maria Gianniou,
  • Evangelia J. Papakonstantinou and
  • Loukianos S. Rallidis

25 January 2025

Pharmaceutical advancements and an improved understanding of pathophysiology have enabled innovative therapies for chronic conditions like dyslipidemia. This condition is marked by abnormalities in lipid homeostasis. Nucleic acid therapeutics, includ...

  • Review
  • Open Access
60 Citations
9,182 Views
23 Pages

A Half-Century History of Applications of Antisense Oligonucleotides in Medicine, Agriculture and Forestry: We Should Continue the Journey

  • Volodymyr V. Oberemok,
  • Kateryna V. Laikova,
  • Anna I. Repetskaya,
  • Igor M. Kenyo,
  • Mikhail V. Gorlov,
  • Igor N. Kasich,
  • Alisa M. Krasnodubets,
  • Nikita V. Gal’chinsky,
  • Iryna I. Fomochkina and
  • Aleksei S. Zaitsev
  • + 13 authors

Antisense oligonucleotides (ASO), short single-stranded polymers based on DNA or RNA chemistries and synthesized in vitro, regulate gene expression by binding in a sequence-specific manner to an RNA target. The functional activity and selectivity in...

  • Review
  • Open Access
33 Citations
6,582 Views
23 Pages

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases

  • Valentina Giudice,
  • Francesca Mensitieri,
  • Viviana Izzo,
  • Amelia Filippelli and
  • Carmine Selleri

Aptamers or chemical antibodies are single-stranded DNA or RNA oligonucleotides that bind proteins and small molecules with high affinity and specificity by recognizing tertiary or quaternary structures as antibodies. Aptamers can be easily produced...

  • Article
  • Open Access
1 Citations
3,187 Views
13 Pages

A Novel Pot-Economy Approach to the Synthesis of Triantennary GalNAc-Oligonucleotide

  • Artem Evgenievich Gusev,
  • Vladimir Nikolaevich Ivanov,
  • Nikolai Andreevich Dmitriev,
  • Aleksandr Viktorovich Kholstov,
  • Vladislav Aleksandrovich Vasilichin,
  • Ilya Andreevich Kofiadi and
  • Musa Rakhimovich Khaitov

17 December 2024

N-Acetylgalactosamine (GalNAc) is an efficient and multifunctional delivery tool in the development and synthesis of chemically modified oligonucleotide therapeutics (conjugates). Such therapeutics demonstrate improved potency in vivo due to the sele...

  • Abstract
  • Open Access
1 Citations
1,922 Views
2 Pages

Aptamers are nucleic acid ligands which exhibit specific binding to a desired target. Oligonucleotides are limited in their ability to form hydrophobic interactions. The affinity of aptamers can be improved with the introduction of hydrophobic modifi...

  • Article
  • Open Access
8 Citations
4,226 Views
13 Pages

Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA)

  • Vibhav Valsangkar,
  • Sweta Vangaveti,
  • Goh Woon Lee,
  • Walid M. Fahssi,
  • Waqas S. Awan,
  • Yicheng Huang,
  • Alan A. Chen and
  • Jia Sheng

30 July 2021

The thrombin binding aptamer (TBA) is a promising nucleic acid-based anticoagulant. We studied the effects of chemical modifications, such as dendrimer Trebler and NHS carboxy group, on TBA with respect to its structures and thrombin binding affinity...

  • Review
  • Open Access
35 Citations
8,672 Views
27 Pages

The development of novel target therapies based on the use of RNA interference (RNAi) and antisense oligonucleotides (ASOs) is growing in an exponential way, challenging the chance for the treatment of the genetic diseases and cancer by hitting selec...

  • Article
  • Open Access
17 Citations
5,073 Views
16 Pages

Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity

  • Hiro Uemachi,
  • Yuuya Kasahara,
  • Keisuke Tanaka,
  • Takumi Okuda,
  • Yoshihiro Yoneda and
  • Satoshi Obika

Nucleic acid aptamers have attracted considerable attention as next-generation pharmaceutical agents and delivery vehicles for small molecule drugs and therapeutic oligonucleotides. Chemical modification is an effective approach for improving the fun...

  • Review
  • Open Access
14 Citations
6,285 Views
16 Pages

Antisense Therapy for Infectious Diseases

  • Lwanda Abonga Buthelezi,
  • Shandre Pillay,
  • Noxolo Nokukhanya Ntuli,
  • Lorna Gcanga and
  • Reto Guler

21 August 2023

Infectious diseases, particularly Tuberculosis (TB) caused by Mycobacterium tuberculosis, pose a significant global health challenge, with 1.6 million reported deaths in 2021, making it the most fatal disease caused by a single infectious agent. The...

of 2